Company intelligence / Profile preview

Askel Healthcare

Helsinki, Uusimaa, Finlandaskelhealthcare.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Askel Healthcare has developed the COPLA® biodegradable polymer scaffold implant for surgical repair of full-thickness knee cartilage defects. The device enables immediate weight-bearing post-surgery and aims to prevent progression to osteoarthritis. The first-in-human safety study has been completed with twenty patients enrolled. The company seeks further funding to support pivotal trials required for regulatory approval in Europe and the US.

Therapeutic areas: Rheumatology
Modalities: Device (biodegradable polymer scaffold)Biomaterial-based implantRegenerative medicine platform
Industry: Implantable Medical Devices

Partnerships

Collaborations with University of Helsinki and Tampere University during R&D phase; no major pharma/biotech partnerships disclosed.

Beyond the preview

Go deeper on Askel Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Askel Healthcare.

Explore the full profile